NCT06649136View on ClinicalTrials.gov

MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis

PHASE4RecruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Methotrexate

comparison between oral and subcutaneous methotrexate dosis of 25mg

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
collaborator

Leiden University Medical Center

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

Queen Mary University of London

OTHER

collaborator

Diakonhjemmet Hospital AS

UNKNOWN

lead

Medical University of Vienna

OTHER